Brainsway Ltd. Logo

Brainsway Ltd.

Develops noninvasive Deep TMS therapy for depression, OCD, and smoking cessation.

BWAY | TA

Overview

Corporate Details

ISIN(s):
IL0011007189
LEI:
Country:
Israel
Address:
16 Hartum St, 9777516 Har Hotzvim, Jerusalem
Sector:
Manufacturing
Industry:
Manufacture of irradiation, electromedical and electrotherapeutic equipment

Description

BrainsWay Ltd. is a global medical technology company specializing in the development and commercialization of advanced noninvasive neurostimulation treatments for mental health disorders. The company's core technology is its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform, which utilizes a patented H-coil to safely stimulate deeper and broader regions of the brain. BrainsWay's systems are FDA-cleared for treating a range of conditions, including Major Depressive Disorder (MDD), Anxious Depression, Obsessive-Compulsive Disorder (OCD), and as an aid for short-term smoking cessation in adults. The company holds the first FDA clearance for a noninvasive medical device for OCD and the first in the addiction space for any TMS device.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-17 15:30
Regulatory News Service
BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use…
Hebrew (modern) 133.9 KB
2025-11-17 15:30
Report Publication Announcement
BrainsWay Launches First Clinical Trial of Deep TMS 360™ System for Alcohol Use…
English 36.6 KB
2025-11-13 14:00
Regulatory News Service
BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depr…
Hebrew (modern) 84.6 KB
2025-11-13 14:00
Foreign Filer Report
BrainsWay Receives FDA Clearance of Deep TMS™ as Adjunct Therapy for Major Depr…
English 36.7 KB
2025-11-12 15:00
Regulatory News Service
BrainsWay November 2025 Investor Presentation
Hebrew (modern) 4.1 MB
2025-11-12 15:00
Report Publication Announcement
BrainsWay November 2025 Investor Presentation
English 36.5 KB
2025-11-12 14:00
Regulatory News Service
BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highligh…
Hebrew (modern) 180.2 KB
2025-11-12 14:00
Report Publication Announcement
BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highligh…
English 36.5 KB
2025-11-11 15:30
Regulatory News Service
BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highligh…
Hebrew (modern) 271.3 KB
2025-11-11 15:30
Report Publication Announcement
BrainsWay Reports Third Quarter 2025 Financial Results and Operational Highligh…
English 36.5 KB
2025-11-04 16:00
Foreign Filer Report
BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research …
English 88.1 KB
2025-11-04 16:00
Report Publication Announcement
BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research …
English 36.7 KB
2025-10-27 14:30
Foreign Filer Report
BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Menta…
English 82.4 KB
2025-10-27 14:30
Foreign Filer Report
BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Menta…
English 36.7 KB
2025-10-14 15:00
Foreign Filer Report
Immediate Report
English 176.6 KB

Automate Your Workflow. Get a real-time feed of all Brainsway Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Brainsway Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Brainsway Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Acarix Logo
AI-powered acoustic system for rapid, non-invasive rule-out of Coronary Artery Disease.
Sweden
ACARIX
ACCURAY INC Logo
Develops robotic and image-guided radiation therapy systems for cancer treatment.
United States of America
ARAY
Develops a pain-free breath device to measure blood glucose for diabetes management.
Poland
AME
Alpha Tau Medical Ltd. Logo
Developing Alpha DaRT, a precision alpha-radiation therapy designed to destroy solid tumors.
United States of America
DRTS
ANGIODYNAMICS INC Logo
Develops minimally invasive medical devices for vascular and oncology applications.
United States of America
ANGO
Apyx Medical Corp Logo
Develops helium plasma energy devices for cosmetic and surgical markets.
United States of America
APYX
Arcoma AB Logo
Develops and manufactures advanced digital X-ray and radiology solutions for global healthcare.
Sweden
ARCOMA
ASTERASYS Co., Ltd. Logo
Develops HIFU and body analysis devices for the global aesthetic and healthcare market.
South Korea
450950
Autonomix Medical, Inc. Logo
Developing a platform for real-time nerve mapping and targeted denervation to treat chronic pain.
United States of America
AMIX
Baird Medical Investment Holdings Ltd Logo
Develops microwave ablation devices for minimally invasive treatment of benign and malignant tumors.
United States of America
BDMD

Talk to a Data Expert

Have a question? We'll get back to you promptly.